Contributors
MH
KZ, MH, CG, MY, KMJ, JDC, AGR, BAM, ET, and ASB participated in the conception and design of the study and contributed to the writing of the protocol. RC and SACC provided scientific advice for the protocol and interpretation of the results. MH, MY, and KMJ were investigators treating participants. CG performed all statistical elements of study design and oversight of analysis of the results. BAM, JLK-A, WSH, and AV performed all viral analyses and assessments of the neutralising antibodies. ET supplied the nOPV2 vaccine. All authors contributed to the interpretation of the results. ASB led the writing of the initial drafts of the manuscript on which all authors commented, and all authors agreed with the decision to submit for publication. KZ, ASB, and CG accessed and verified the data and all authors had full access to the data.